×

Sign In

Search
Home

US FDA declines to approve Lexicon Pharma’s add-on diabetes drug

By Thomson Reuters Dec 20, 2024 | 3:46 PM

(Reuters) – The U.S. Food and Drug Administration declined to approve Lexicon Pharmaceuticals’ add-on drug for type 1 diabetes and chronic kidney disease, the company said on Friday.

(Reporting by Puyaan Singh and Sriparna Roy in Bengaluru; Editing by Shreya Biswas)

Champion Dodgers top MLB's list of luxury-tax bills

Seven Chinese nationals tried to illegally enter Guam as U.S. tested missile, authorities say

Google says it could loosen search deals in US antitrust case

US State Dept OKs potential sale of military gear to Taiwan, Pentagon says

Israel military says it failed to intercept missile from Yemen after sirens sounded in central Israel

Biden administration withdraws proposed rule limiting transgender bans in sports

Privacy Policy
Terms Of Service

Midwest Communications, Inc.

Copyright © 2024. All Rights Reserved.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.